<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Per capita sales of <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi> in Hong Kong (which presumably reflect adult and pediatric consumption in the community) are between about 11 to 442 fold greater than in several western countries and Australia </plain></SENT>
<SENT sid="1" pm="."><plain>Despite such relatively excessive exposure to a potentially marrow-damaging drug, the certified <z:hpo ids='HP_0011420'>death</z:hpo> rate from <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> in Hong Kong was only 0.4 per 1000 <z:hpo ids='HP_0011420'>deaths</z:hpo> compared with 1.0 per 1000 in England and Wales </plain></SENT>
<SENT sid="2" pm="."><plain>Nor was there any other evidence to indicate that Hong Kong residents suffered an excessive incidence of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Wherever <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi> use is widespread, prospective investigations should be undertaken in the local population to evaluate the alleged high risks of producing <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
</text></document>